People with hemophilia are living longer, but Black males still are more likely to die from the disease, and…
Articles by Margarida Maia, PhD
Switching from on-demand treatment to regular preventive therapy with extended half-life products may mean fewer bleeds, healthier joints, and better…
More bleeding episodes may mean a lower quality of life and less productivity at work for men with hemophilia…
Regulatory agencies in the U.S. and Europe are reviewing applications seeking the approval of fidanacogene elaparvovec, an experimental one-time…
A researcher at the University at Buffalo has won a three-year grant worth $1.5 million to develop a way to…
Hemophilia treatments in Thailand are limited due to a lack of budgetary resources, the high cost of medications, and…
Female hemophilia AÂ patients and carriers have more frequent bleeding than males, yet a much smaller proportion receive…
Xoma closed a $9.6 million deal to buy from Aptevo Therapeutics the rights to receive a payment stream for…
Preventive treatment with Hemlibra (emicizumab) appears to be safe and helps keep bleeding under control in babies who have…
SerpinPC, a potential treatment for all types of hemophilia, from the drug development pipeline at Centessa Therapeutics, was…